We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOB icon
1676
Live Oak Bancshares
LOB
$1.95B
$43K ﹤0.01%
2,496
+1,368
+121% +$22.5K
NAVI icon
1677
Navient
NAVI
$796M
$43K ﹤0.01%
3,164
-15,400
-83% -$201K
PHUN icon
1678
Phunware
PHUN
$41.7M
$43K ﹤0.01%
+278
New +$84.6K
SCHP icon
1679
Schwab US TIPS ETF
SCHP
$16.2B
$43K ﹤0.01%
+1,510
New +$41.8K
SCO icon
1680
ProShares UltraShort Bloomberg Crude Oil
SCO
$598M
$43K ﹤0.01%
31
+28
+933% +$37.7K
SNBR
1681
DELISTED
Sleep Number
SNBR
$43K ﹤0.01%
+1,068
New +$41.3K
TROX icon
1682
Tronox
TROX
$993M
$43K ﹤0.01%
+3,350
New +$41K
TWST icon
1683
Twist Bioscience
TWST
$7.83B
$43K ﹤0.01%
1,484
+1,251
+537% +$33.1K
CNH
1684
CNH Industrial
CNH
$16.9B
$43K ﹤0.01%
4,856
-48,530
-91% -$422K
ETRN
1685
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$43K ﹤0.01%
2,162
-9,197
-81% -$191K
NEPT
1686
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$43K ﹤0.01%
7
+5
+250% +$28.5K
AERI
1687
DELISTED
Aerie Pharmaceuticals
AERI
$43K ﹤0.01%
1,458
+1,398
+2,330% +$53.9K
SHLX
1688
DELISTED
Shell Midstream Partners, L.P.
SHLX
$43K ﹤0.01%
+2,053
New +$42.2K
XLNX
1689
DELISTED
Xilinx Inc
XLNX
$43K ﹤0.01%
370
-7,863
-96% -$917K
RNWK
1690
DELISTED
RealNetworks Inc
RNWK
$43K ﹤0.01%
22,320
+405
+2% +$923
ABEO icon
1691
Abeona Therapeutics
ABEO
$425M
$42K ﹤0.01%
349
+284
+437% +$47.6K
ALRM icon
1692
Alarm.com
ALRM
$2.79B
$42K ﹤0.01%
+778
New +$48K
BALL icon
1693
Ball Corp
BALL
$16.6B
$42K ﹤0.01%
590
-9,965
-94% -$619K
CATY icon
1694
Cathay General Bancorp
CATY
$4.23B
$42K ﹤0.01%
1,168
-3,471
-75% -$123K
DOC icon
1695
Healthpeak Properties
DOC
$14.4B
$42K ﹤0.01%
1,306
-16,621
-93% -$517K
DY icon
1696
Dycom Industries
DY
$12B
$42K ﹤0.01%
721
-128
-15% -$6.55K
ESRT icon
1697
Empire State Realty Trust
ESRT
$802M
$42K ﹤0.01%
2,831
-4,812
-63% -$74.5K
FCN icon
1698
FTI Consulting
FCN
$4.17B
$42K ﹤0.01%
500
-235
-32% -$19.3K
FMS icon
1699
Fresenius Medical Care
FMS
$13B
$42K ﹤0.01%
1,078
+733
+212% +$29K
GERN icon
1700
Geron
GERN
$949M
$42K ﹤0.01%
29,801
+24,684
+482% +$40.8K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.